Deepbridge Life Sciences EIS
The Deepbridge Life Sciences EIS represents an opportunity for private investors to participate in a selected portfolio of healthcare innovation, whilst taking advantage of the tax benefits available under the Enterprise Investment Scheme. The investment strategy of the Deepbridge Life Sciences EIS is to invest in a diversified portfolio of up to ten investee companies that participate in one of the following:
- Medical Technology.
The Deepbridge Life Sciences EIS is not an Unregulated Collective Investment Scheme.
- An engaged hands-on approach from an experienced investment management team
- Free of fees to the Investor, 100% allocation of investor funds
- All EIS tax advantages applicable
- Target return of 22.4% p.a. over a minimum of 4 years
- Performance fee aligned to the investors interests
The 100% Rule
The Deepbridge Life Sciences EIS is an investor fee-free EIS opportunity, when introduced via an authorised and regulated financial adviser. Investors are therefore not charged any fees at point of investment. Upfront and ongoing fees are paid by the Investee Companies: this advantage allows investors to enjoy 100% of EIS tax benefits and to have 100% of their investment actually put to work earning investment returns.
The Target Return
The investment objective of the Deepbridge Life Sciences EIS is to generate substantial tax-efficient mid-case capital growth of 170p for every 100p invested, over a 4-5 year period.
Exit events will be sought at the earliest opportunity after the third anniversary of the investment made.
Who Is The Deepbridge Life Sciences EIS Targeting?
The Deepbridge Life Sciences EIS is targeting UK taxpaying individuals:
- Seeking an attractive, medium term investment opportunity
- With income tax liability in the preceding and/or current tax years
- With large capital gains to defer
- Who will benefit from IHT relief.
The minimum individual investment in the Deepbridge EIS is £10,000. Investors should note that their investment comprises of shares in small unquoted companies (often with high risk) and that they are unlikely to have access to their capital for at least 3-4 years from the date of application. Please refer to the risk section for further information.
Information on this webpage relates to and is provided by Deepbridge Advisers Limited.
The content of this webpage is for intermediary use only and should not be construed as financial advice.
Information contained on this section of the website is intended for financial advisers and relevant intermediaries only. It contains information intended for financial advisers, wealth managers and private advisers only.
To access this section of the website you must confirm that you are a financial adviser authorised and regulated by the Financial Conduct Authority.